Satiogen Pharmaceuticals, Inc.

États‑Unis d’Amérique

 
Quantité totale PI 13
Rang # Quantité totale PI 116 945
Note d'activité PI 1,1/5.0    3
Rang # Activité PI 339 187

Brevets

Marques

8 0
1 0
4 0
0
 
Dernier brevet 2022 - Bile acid recycling inhibitors a...
Premier brevet 2006 - Biliary/pancreatic shunt device ...

Derniers inventions, produits et services

2022 Invention Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory...
2016 Invention Methods of treating diabetes or obesity using bile acids, bile salts, and mimics thereof. Provide...
Invention Bile acid recycling inhibitors for treatment of obesity and diabetes. Provided herein are methods...
2012 Invention Methods and apparatus for treating obesity and diabetes. Provided herein are methods and shunt d...
Invention Bile acid recycling inhibitors for treatment of obesity and diabetes. Provided herein are method...
2010 Invention Treatment of obesity or diabetes with bile acid sequestrants. Provided herein are methods of tre...
Invention Treatment of obesity or diabetes with bile acid sequestrants. Provided herein are methods of trea...
2009 Invention Bile acid recycling inhibitors for treatment of obesity and diabetes. Provided herein are Apical ...
Invention Use of compositions comprising bile acids, salts, and mimics thereof for the treatment of obesity...
Invention Compositions containing satiogens and methods of use. Provided herein are methods and composition...
Invention Methods of treating diabetes and/or obesity using an enteroendocrine peptide secretion enhancing ...
2006 Invention Biliary/pancreatic shunt device and method for treatment of metabolic and other diseases. Provide...